- +

What is the Micro-Needle?

Do you hate getting shots because of the pain? An exciting new breakthrough from PKA SoftTouch lets you administer your meds by injection virtually painlessly. The small and inexpensive Micro-Needle is the ONLY device that lets you inject only into the skin layers where there are no nerves and NO PAIN.

History and background

Research began in October 2005 to design and develop a cost-effective, painless, minimally invasive medical device technology for the treatment of chronic diseases such as diabetes.
Completed a successful working prototype.
Achieved successful proof of concepts for US FDA and Health Canada suggested animal/human clinical trials.
Received North American and International patent protection.
Founders have over 60 years of combined experience in drug delivery systems.
Founders have extensive experience in the pharmaceutical industry and with insulin technology.

Vision

Design and develop a cost-effective, non-invasive medical device technology for the treatment of chronic diseases such as diabetes.
Develop the product for entry into the worldwide insulin market based on PKA SoftTouch experience with insulin.
Improve the quality of life and enhanced value for patients by painless injections of life saving drugs.

Milestones achieved

'Safety and Efficacy Evaluation of the Micro-needle Insulin Injection of Healthy Dogs', University of Guelph
Clinical Study to evaluate the performance of the Micro-needle Injection Device in dogs using Atropine, University of Guelph
Proof of Concept Human Clinical Trial Data in Type-1 Diabetics (St. Joseph Hospital, Diabetes Research Unit, Toronto)
The device was recently cleared by the US-FDA for large scale human clinical trials related to insulin and/or heparin
Canadian and South African patents have been issued.
U.S. Patent is pending.
International patents are pending.
PKA SoftTouch has developed and perfected technology to stabilize insulin at room temperatures. This is exclusive and will be patent protected.